Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

If Early Warning Systems Were Used, Could the Risk of Early Clinical Deterioration be Predicted and Re-admission to Intensive Care Could be Prevented

NCT03912701 is registered in ClinicalTrials.gov with Erzincan University as lead sponsor.

NCT NCT03912701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
If Early Warning Systems Were Used, Could the Risk of Early Clinical Deterioration be Predicted and Re-admission to Intensive Care Could be Prevented
Lead sponsor
Erzincan University
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2019
Completion date
November 15, 2019
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early clinical deterioration